Literature DB >> 2877083

Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.

Z Zukowska-Grojec, M Haass, I J Kopin, N Zamir.   

Abstract

We have found previously that atrial natriuretic peptides (ANPs) attenuate pressor response to alpha-2 adrenoceptor agonists but not to alpha-1 agonists in the pithed rat. We have now investigated the effects of ANP on other pressor agonists and on sympathetically mediated responses in rats. Bolus-injected ANP (0.1-10.0 nmol/kg) attenuated pressor responses to angiotensin II, vasopressin and alpha-2 adrenoceptor-mediated component of norepinephrine (NE)-induced responses (up to 17, 27 and 15%, respectively) in pithed rats. The threshold antipressor dose of ANP was the lowest for angiotensin II (comparable to normal levels of circulating ANP-immunoreactivity in rats) whereas it was higher for vasopressin and NE (comparable to plasma ANP-immunoreactivity stimulated by volume expansion). A 30-min infusion of ANP (0.15 nmol/kg/min) shifted the NE dose-pressor response curve 1.7-fold to the right. Conversely, neither that rate of ANP infusion nor the highest dose of bolus injected ANP altered pressor and plasma NE responses to sympathetic stimulation in demedullated pithed rats. However, at higher infusion rates, ANP reduced sympathetic stimulation-induced pressor responses (2.6-fold) and elevations of plasma NE levels (1.6-fold), without altering NE clearance. Similarly in conscious rats, ANP infusion prevented a reflex increase in plasma NE concentrations associated with hypotension. Thus, although the intrajunctional alpha-1 and presynaptic alpha-2 adrenoceptors are inaccessible to the short term bolus-induced elevation of circulating ANP during longer term increases in plasma ANP, it does reach the junction, reduces NE release and limits effects of receptor activation, possibly by diminishing Ca++ entry.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877083

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Atrial natriuretic peptide level and intracardiac pressure in cardiac transplant recipients.

Authors:  G Deray; G Maistre; M Desruenne; J Eurin; C Barthelemy; F Masson; A Baumelou; P Leger; C Cabrol; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

Review 3.  Peptides in the mammalian cardiovascular system.

Authors:  J Wharton; S Gulbenkian
Journal:  Experientia       Date:  1987-07-15

4.  Muscarinic effect of atrial natriuretic peptide on rabbit airways.

Authors:  A Robichaud; C Saunier; M C Michoud; P du Souich
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

5.  Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats.

Authors:  Z Zukowska-Grojec; M Golczynska; G H Shen; A Torres-Duarte; M Haass; C Wahlestedt; A K Myers
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

6.  Only pharmacological doses of atrial natriuretic peptide affect intestinal ion transport in non-volume expanded rats.

Authors:  R Lübcke; J Brunner; F A Hutcheson; G O Barbezat
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.